Sort   by:  
 Page size 
UnknownCharacterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Not available
S-EPMC10835978 | biostudies-literature
UnknownRelationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.
Not available
S-EPMC11297788 | biostudies-literature
UnknownEchocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial.
Not available
S-EPMC11730511 | biostudies-literature
UnknownThe pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Not available
S-EPMC11087475 | biostudies-literature
UnknownSodium-glucose co-transporter 2 inhibitors in severe estimated glomerular filtration rate deterioration across cardiovascular-kidney- metabolic conditions: A pooled analysis of randomized trials.
Not available
S-EPMC12765462 | biostudies-literature
UnknownEffects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials.
Not available
S-EPMC12803639 | biostudies-literature
UnknownConsensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach.
Not available
S-EPMC6223445 | biostudies-literature
UnknownPatiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Not available
S-EPMC9622299 | biostudies-literature
UnknownEmpagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Not available
S-EPMC11973566 | biostudies-literature
UnknownA-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
Not available
S-EPMC5953833 | biostudies-literature
Sort   by:  
 Page size